CIP2A and hepatocellular carcinoma: Out of two studies (He et al., 2012; Huang C.Y et al., 2012), He et al. concluded that the high expression of CIP2A/p90 can predict poor outcome in patients with hepatocellular carcinoma, and therefore, this can be used as a significant prognostic factor for DFS and OS (He et al., 2012).